NCT02374996View on ClinicalTrials.gov

Pharmacoepigenetics of Bipolar Disorder Treatment

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Antipsychotic AgentsBipolar Disorder
Trial Locations (1)

48202

Wayne State University Clinical Research Center, Detroit

All Listed Sponsors
lead

Wayne State University

OTHER

NCT02374996 - Pharmacoepigenetics of Bipolar Disorder Treatment | Biotech Hunter | Biotech Hunter